Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F1WPE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $58,076
Award facts
- Contract value 100% obligated
- $58,075.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $58,075.98 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose in 2-pen/mL format. This non-competitive delivery order was issued on December 3, 2025, with an ultimate completion date of December 4, 2025. The contract utilizes firm fixed-price terms and represents a medical pharmaceutical delivery under the DLA's pharmaceutical supply chain operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor for this award.
This delivery order falls under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare systems worldwide. Cosentyx, a biologic immunosuppressant, supports the Defense Health Agency and other federal healthcare systems' requirements for specialty pharmaceutical treatments. The delivery order reflects AmerisourceBergen's established capability to fulfill federal medical procurement needs through its competitive positioning on the DLA's pharmaceutical prime vendor contract.
Quick answers
Who was awarded contract SPE2DR26F1WPE?
SPE2DR26F1WPE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26F1WPE worth?
The government has obligated $58,076 on SPE2DR26F1WPE.
Is contract SPE2DR26F1WPE an order under another contract?
Yes. SPE2DR26F1WPE is a delivery order under SPE2DR25D3402, an indefinite delivery contract.
Was contract SPE2DR26F1WPE competed?
The extent of competition for SPE2DR26F1WPE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award